200 related articles for article (PubMed ID: 35406613)
1. Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine Repertoires.
Grunert C; Willimsky G; Peuker CA; Rhein S; Hansmann L; Blankenstein T; Blanc E; Beule D; Keller U; Pezzutto A; Busse A
Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406613
[TBL] [Abstract][Full Text] [Related]
2. Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells.
Kato T; Matsuda T; Ikeda Y; Park JH; Leisegang M; Yoshimura S; Hikichi T; Harada M; Zewde M; Sato S; Hasegawa K; Kiyotani K; Nakamura Y
Oncotarget; 2018 Feb; 9(13):11009-11019. PubMed ID: 29541393
[TBL] [Abstract][Full Text] [Related]
3. Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma.
Wei T; Leisegang M; Xia M; Kiyotani K; Li N; Zeng C; Deng C; Jiang J; Harada M; Agrawal N; Li L; Qi H; Nakamura Y; Ren L
Oncoimmunology; 2021 May; 10(1):1929726. PubMed ID: 34104546
[TBL] [Abstract][Full Text] [Related]
4. Detection of mutant antigen-specific T cell receptors against multiple myeloma for T cell engineering.
Okada M; Shimizu K; Nakazato H; Yamasaki S; Fujii SI
Mol Ther Methods Clin Dev; 2023 Jun; 29():541-555. PubMed ID: 37359417
[TBL] [Abstract][Full Text] [Related]
5. Public T-Cell Receptors (TCRs) Revisited by Analysis of the Magnitude of Identical and Highly-Similar TCRs in Virus-Specific T-Cell Repertoires of Healthy Individuals.
Huisman W; Hageman L; Leboux DAT; Khmelevskaya A; Efimov GA; Roex MCJ; Amsen D; Falkenburg JHF; Jedema I
Front Immunol; 2022; 13():851868. PubMed ID: 35401538
[TBL] [Abstract][Full Text] [Related]
6. Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors.
Immisch L; Papafotiou G; Gallarín Delgado N; Scheuplein V; Paschen A; Blankenstein T; Willimsky G
Front Immunol; 2023; 14():1119498. PubMed ID: 36875127
[TBL] [Abstract][Full Text] [Related]
7. Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer.
Liu S; Matsuzaki J; Wei L; Tsuji T; Battaglia S; Hu Q; Cortes E; Wong L; Yan L; Long M; Miliotto A; Bateman NW; Lele SB; Chodon T; Koya RC; Yao S; Zhu Q; Conrads TP; Wang J; Maxwell GL; Lugade AA; Odunsi K
J Immunother Cancer; 2019 Jun; 7(1):156. PubMed ID: 31221207
[TBL] [Abstract][Full Text] [Related]
8. Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma.
Ren L; Leisegang M; Deng B; Matsuda T; Kiyotani K; Kato T; Harada M; Park JH; Saloura V; Seiwert T; Vokes E; Agrawal N; Nakamura Y
Oncoimmunology; 2019; 8(4):e1568813. PubMed ID: 30906664
[TBL] [Abstract][Full Text] [Related]
9. Induction of neoantigen-reactive T cells from healthy donors.
Ali M; Foldvari Z; Giannakopoulou E; Böschen ML; Strønen E; Yang W; Toebes M; Schubert B; Kohlbacher O; Schumacher TN; Olweus J
Nat Protoc; 2019 Jun; 14(6):1926-1943. PubMed ID: 31101906
[TBL] [Abstract][Full Text] [Related]
10. Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing.
Lu YC; Zheng Z; Lowery FJ; Gartner JJ; Prickett TD; Robbins PF; Rosenberg SA
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34321276
[TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating human CD4
Ahmadzadeh M; Pasetto A; Jia L; Deniger DC; Stevanović S; Robbins PF; Rosenberg SA
Sci Immunol; 2019 Jan; 4(31):. PubMed ID: 30635355
[TBL] [Abstract][Full Text] [Related]
12. Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma.
Tan Q; Zhang C; Yang W; Liu Y; Heyilimu P; Feng D; Xing L; Ke Y; Lu Z
J Immunother Cancer; 2019 Aug; 7(1):232. PubMed ID: 31462302
[TBL] [Abstract][Full Text] [Related]
13. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI
Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma.
Bräunlein E; Lupoli G; Füchsl F; Abualrous ET; de Andrade Krätzig N; Gosmann D; Wietbrock L; Lange S; Engleitner T; Lan H; Audehm S; Effenberger M; Boxberg M; Steiger K; Chang Y; Yu K; Atay C; Bassermann F; Weichert W; Busch DH; Rad R; Freund C; Antes I; Krackhardt AM
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34518289
[TBL] [Abstract][Full Text] [Related]
15. The Ways of Isolating Neoantigen-Specific T Cells.
Li Q; Ding ZY
Front Oncol; 2020; 10():1347. PubMed ID: 32850430
[TBL] [Abstract][Full Text] [Related]
16. Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.
Parkhurst M; Gros A; Pasetto A; Prickett T; Crystal JS; Robbins P; Rosenberg SA
Clin Cancer Res; 2017 May; 23(10):2491-2505. PubMed ID: 27827318
[No Abstract] [Full Text] [Related]
17. TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs.
Genolet R; Bobisse S; Chiffelle J; Arnaud M; Petremand R; Queiroz L; Michel A; Reichenbach P; Cesbron J; Auger A; Baumgaertner P; Guillaume P; Schmidt J; Irving M; Kandalaft LE; Speiser DE; Coukos G; Harari A
Cell Rep Methods; 2023 Apr; 3(4):100459. PubMed ID: 37159666
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity.
Mariuzza RA; Wu D; Pierce BG
Front Immunol; 2023; 14():1303304. PubMed ID: 38045695
[TBL] [Abstract][Full Text] [Related]
19. TCR function analysis using a novel system reveals the multiple unconventional tumor-reactive T cells in human breast cancer-infiltrating lymphocytes.
Yamaguchi S; Hamana H; Shitaoka K; Sukegawa K; Nagata T; Hayee A; Kobayashi E; Ozawa T; Fujii T; Muraguchi A; Tobe K; Kishi H
Eur J Immunol; 2021 Sep; 51(9):2306-2316. PubMed ID: 34171120
[TBL] [Abstract][Full Text] [Related]
20. Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies.
Tubb VM; Schrikkema DS; Croft NP; Purcell AW; Linnemann C; Freriks MR; Chen F; Long HM; Lee SP; Bendle GM
J Immunother Cancer; 2018 Jul; 6(1):70. PubMed ID: 30001747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]